Premium
Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID‐19: coincidence or underestimated risk factor?
Author(s) -
Luxenburger H.,
Sturm L.,
Biever P.,
Rieg S.,
Duerschmied D.,
Schultheiss M.,
NeumannHaefelin C.,
Thimme R.,
Bettinger D.
Publication year - 2021
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.13121
Subject(s) - medicine , ards , pneumonia , risk factor , proton pump inhibitor , medical record , covid-19 , disease , intensive care medicine , pediatrics , lung , infectious disease (medical specialty)